BioSIMS Technologies

BioSIMS Technologies was a French life sciences tools and diagnostics company focused on highly sensitive protein detection and quantification. The company developed the DYNAXI platform, a multiplex protein microarray and secondary ion mass spectrometry approach intended for biomarker analysis, research-use assays, and eventually in vitro diagnostics. Its technology aimed to measure very low-abundance analytes without fluorescent labeling or signal amplification, with applications in oncology and chronic inflammatory diseases. BioSIMS also offered biochip-related services such as assay development, spotting, hybridization, and design validation. Available sources indicate the company later entered liquidation and is no longer active.